XML 78 R36.htm IDEA: XBRL DOCUMENT v3.20.1
EMPLOYEE STOCK COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Summary of Share-Based Compensation Expense
The following table presents stock-based compensation expense and the related tax benefits for the periods indicated:
 
 
Three Months Ended March 31,
($ in thousands)
 
2020
 
2019
Stock options
 
$
2

 
$
8

Restricted stock awards and units
 
1,574

 
845

Total share-based compensation expense
 
$
1,576

 
$
853

Related tax benefits
 
$
464

 
$
251


Unrecognized Share-Based Compensation Expense
The following table presents unrecognized stock-based compensation expense as of March 31, 2020:
($ in thousands)
 
Unrecognized Expense
 
Weighted-Average Remaining Expected Recognition Period
Stock option awards
 
$
2

 
0.2 years
Restricted stock awards and restricted stock units
 
10,447

 
2.5 years
Total
 
$
10,449

 
2.5 years

Option Activity
The following table represents stock option activity for the three months ended March 31, 2020:
 
 
Three Months Ended March 31, 2020
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
62,521

 
$
13.85

 
4.3 years
 
 
Exercised
 
(7,452
)
 
$
13.05

 
5.2 years
 
 
Outstanding at end of period
 
55,069

 
$
13.96

 
4.0 years
 
$
(344
)
Exercisable at end of period
 
52,821

 
$
13.97

 
3.9 years
 
$
(330
)

Nonvested Share
The following table sets forth information regarding unvested stock options for the three months ended March 31, 2020:
 
 
Three Months Ended March 31, 2020
 
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
Outstanding at beginning of period
 
2,248

 
$
13.75

Vested
 

 
$

Forfeited
 

 
$

Outstanding at end of period
 
2,248

 
$
13.75


Restricted Stock and Restricted Stock Units Activity The following table presents unvested restricted stock awards and restricted stock units activity for the three months ended March 31, 2020:
 
 
Three Months Ended March 31, 2020
 
 
Number of Shares
 
Weighted Average Grant Date Fair Value Per Share
Outstanding at beginning of period
 
923,482

 
$
15.74

Granted (1)
 
269,138

 
$
15.33

Vested (2)
 
(62,333
)
 
$
15.44

Forfeited (3)
 
(47,180
)
 
$
15.92

Outstanding at end of period
 
1,083,107

 
$
15.65


(1)
There were 78,771 performance-based shares/units included in shares granted for the three months ended March 31, 2020.
(2)
There were 5,399 performance-based shares/units included in vested shares for the three months ended March 31, 2020.
(3)
The number of forfeited shares includes aggregate performance-based shares/units of 15,622 for the three months ended March 31, 2020.
Summary of all Outstanding SARs
The following table represents SARs activity and the weighted average exercise price per share as of and for the three months ended March 31, 2020:
 
 
Three Months Ended March 31, 2020
($ in thousands except per share data)
 
Number of Shares
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Remaining Contract Term
 
Aggregated Intrinsic Value
Outstanding at beginning of period
 
1,559,012

 
$
11.60

 
2.6 years
 
$
8,508

Outstanding at end of period
 
1,559,012

 
$
11.60

 
2.4 years
 
$
(6,503
)
Exercisable at end of period
 
1,559,012

 
$
11.60

 
2.4 years
 
$
(6,503
)